🔎 Trials Near Me

Utama › Poliradikuloneuropati Demielinasi Inflamatori Kronik › Florida

Kajian klinikal Poliradikuloneuropati Demielinasi Inflamatori Kronik di Florida

11 kajian untuk Poliradikuloneuropati Demielinasi Inflamatori Kronik sedang mencari peserta di lokasi di Florida.

Bandar di Florida

Teks kajian rasmi (Bahasa Inggeris)

Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

  • Site Number - 1603, Maitland
  • Site Number - 1606, Miami
  • Site Number - 1617, Ormond Beach
  • dan 2 lagi
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT07032662

Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

  • Healthcare Innovations Institute Inc, Coral Springs
  • ALS Center at the University of Miami, Miami
Mengambil pesertaFasa 2/3
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT05327114

A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP

  • Gables Neurology, Miami
  • Aqualane Clinical Research, Naples
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 24 Sep 2026 · NCT07091630

A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP

  • Homestead Associates in Research Inc, Homestead
  • Visionary Investigators Network, Miami
  • University of South Florida, Tampa
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 24 Sep 2026 · NCT06920004

A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

  • Nova Clinical Research - Bradenton- Site Number : 8400044, Bradenton
  • Research by Design, LLC- Site Number : 8400053, Miami Lakes
  • AdventHealth Orlando- Site Number : 8400006, Orlando
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT06290141

A Study Investigating Intravenous Human Normal Immune Globulin (IGIV) 10% KIg10 (QIVIGY) in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

  • Quantix Research, Miami
  • USF Health - Morsani Center for Advanced Healthcare, Tampa
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 11 Sep 2026 · NCT06752356

A Study to Evaluate the Pharmacokinetics and Safety of XEMBIFY Versus Gamunex-C in Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy

  • GC2402 Study Site 109, Coral Springs
  • GC2402 Study Site 103, Port Charlotte
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 4 Sep 2026 · NCT07540221

A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)

  • Clinical Study Site, Maitland
  • Clinical Study Site, Tampa
Mengambil pesertaFasa 3
Umur 18 hingga 75 · Semua jantina · Dikemas kini 2 Sep 2026 · NCT06858579

A Study of TAK-411 in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

  • UF Health Neurology - Jacksonville, Jacksonville
  • Visionary Investigators Network, Miami
  • University of South Florida, Tampa
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 23 Apr 2026 · NCT06798012

A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

  • Neurology Associates, Maitland
  • Knight Neurology, Rockledge
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 20 Jan 2026 · NCT06747351

A Study of HyQvia in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) in Routine Clinical Care

  • Nova Clinical Research, LLC, Bradenton
  • Suncoast Neuroscience Associates, Inc., St. Petersburg
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 21 Nov 2025 · NCT06538064

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.